Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fixed Dose Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory Chemotherapy-Induced Nausea and Vomiting

NCT03008213 is registered in ClinicalTrials.gov with Joseph Ma as lead sponsor.

NCT NCT03008213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03008213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fixed Dose Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory Chemotherapy-Induced Nausea and Vomiting
Lead sponsor
Joseph Ma
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2017
Completion date
January 22, 2018
Enrollment
4 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced nausea vomiting